Mayne Pharma Group Limited (ASX: MYX) announced its Abbreviated New Drug Application (ANDA) for generic NuvaRing® has been accepted for filing by the US Food and Drug Administration (FDA). NuvaRing is an intra vaginal hormonal contraceptive delivery device combining etonogestrel … Continue reading Mayne Pharma Group Announces Generic NuvaRing Accepted for Filing by FDA
Sticky post
MGC Pharmaceuticals Ltd (ASX: MXC) is provides the following operational update as it continues to make strong progress across its MGC Pharma, MGC Botanic and MGC Derma divisions. The Company’s core strategic focus remains to build the MGC Pharma business … Continue reading MGC Pharmaceuticals Provides Operational and Strategy Update
MMJ PhytoTech Limited (ASX: MMJ) advised that it has entered into an agreement to acquire a strategic stake in private, Canadian-based healthcare company Dosecann Inc., via the proposed placement of C$2.5 million in secured convertible debenture units . Strategically, the … Continue reading MMJ Phytotech Announces Acquition of Strategic Position in Dosecann Inc
AusCann Group Holdings Ltd (ASX:AC8) announced that it has entered into a Heads of Agreement (HoA) with ASX listed Australian Pharmaceutical Industries Limited (ASX:API) to form a wholesale agreement for the distribution of AusCann’s cannabinoid medicines throughout Australia. The collaboration … Continue reading AusCann Group Holdings Signs HoA with Leading Wholesale Distributor in Australia
Australian Pharmaceutical Industries today said that it expected its half year net profit after tax (NPAT) for the period ending 28 February 2018 will be approximately $26.5 million, and that full year NPAT is expected to be marginally above that … Continue reading Australian Pharmaceutical Industries Provides Trading Update
Creso Pharma Limited (ASX:CPH) announced that it has formally launched its new joint venture company with LGC Capital Ltd (TSXV: LG) and Baltic Beer Company Ltd (“Baltic Beer Company”) to capitalise on the fast-growing cannabis and hempderived beverage markets. The … Continue reading Creso Pharma Announces Launch of JV for Cannabis-Derived Beverage Market
Noxopharm has announced that its US subsidiary, Nyrada Inc, has released an Information Memorandum relating to the raising of AUD$6M by placement of common stock to sophisticated non-US investors. 1,500,000 New Shares are being offered at a price of AU$4.00 … Continue reading Noxopharm Announces Nyrada Opens Capital Raise
Noxopharm and its US subsidiary, Nyrada Inc, are pleased to announce jointly that the experimental drug, NYX-104, has cleared a critical step in its development as a neuroprotective drug. Data released today at the 12th Cerebral Vascular Biology International Conference … Continue reading Noxopharm Announces NYX-104 Delivers Key Proof-of-Concept in Stroke Animal Model
Factor Therapeutics Limited (ASX: FTT), an Australian biomedical company developing therapeutics for advanced wound care, announced passing 50% recruitment in the VF00102 clinical trial. Twice as many patients were enrolled in November than in the previous month, bringing the total … Continue reading Factor Therapeutics Announces 50% Recruitment Reached in VF00102 Clinical Trial
Avita Medical (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced the execution of an expanded contract option valued at approximately US$24.3 million. This newly executed contract option establishes funding … Continue reading Avita Medical Announces the Execution of an Expanded Contract
